Related references
Note: Only part of the references are listed.Molecular imaging of microglia/macrophages in the brain
Sriram Venneti et al.
GLIA (2013)
Microglial Activation and Antioxidant Responses Induced by the Parkinson's Disease Protein α-Synuclein
Dawn Beraud et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Immune Heterogeneity in Neuroinflammation: Dendritic Cells in the Brain
Carol A. Colton
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Comparison of polarization properties of human adult microglia and blood-derived macrophages
Bryce A. Durafourt et al.
GLIA (2012)
Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease
Weilin Xie et al.
JOURNAL OF NEUROCHEMISTRY (2012)
LONG-TERM POLARIZATION OF MICROGLIA UPON α-SYNUCLEIN OVEREXPRESSION IN NONHUMAN PRIMATES
P. Barkholt et al.
NEUROSCIENCE (2012)
Inflammation and Adaptive Immunity in Parkinson's Disease
R. Lee Mosley et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Disruption of Protein Quality Control in Parkinson's Disease
Casey Cook et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Aspects of innate immunity and Parkinson's disease
Yue Huang et al.
FRONTIERS IN PHARMACOLOGY (2012)
Association of GWAS Loci With PD in China
Xue-Li Chang et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2011)
Genome-Wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population
Xinmin Liu et al.
BMC MEDICAL GENETICS (2011)
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
David R. Beers et al.
BRAIN (2011)
Genome-wide association study confirms extant PD risk loci among the Dutch
Javier Simon-Sanchez et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
NSAID use and risk of Parkinson disease: a population-based case-control study
C. Becker et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Autophagic pathways in Parkinson disease and related disorders
Maria Xilouri et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons
Wendou Yu et al.
HUMAN MOLECULAR GENETICS (2011)
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
Niroshana Anandasabapathy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Clinical Subtypes of Parkinson's Disease
Stephanie M. van Rooden et al.
MOVEMENT DISORDERS (2011)
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
Marie-Therese Armentero et al.
NEUROBIOLOGY OF DISEASE (2011)
Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
Dawn Béraud et al.
PARKINSONISM & RELATED DISORDERS (2011)
Neuroprotective activities of regulatory T cells
Howard E. Gendelman et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Features of Microglia and Neuroinflammation Relevant to Environmental Exposure and Neurotoxicity
Andrew D. Kraft et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2011)
Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study
Jane A. Driver et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
alpha-Synuclein alters toll-like receptor expression
Dawn Beraud et al.
FRONTIERS IN NEUROSCIENCE (2011)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Mitochondrial dynamics in cell death and neurodegeneration
Dong-Hyung Cho et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Protein Degradation, Aggregation, and Misfolding
Ana Maria Cuervo et al.
MOVEMENT DISORDERS (2010)
Risk for Parkinson's Disease Among Patients with Osteoarthritis: A Danish Cohort Study
Kathrine Rugbjerg et al.
MOVEMENT DISORDERS (2010)
What Are the Most Important Nonmotor Symptoms in Patients with Parkinson's Disease and Are We Missing Them?
David A. Gallagher et al.
MOVEMENT DISORDERS (2010)
The Nonmotor Symptoms of Parkinson's Disease-An Overview
Shen-Yang Lim et al.
MOVEMENT DISORDERS (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
[C-11]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
A. L. Bartels et al.
PARKINSONISM & RELATED DISORDERS (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
α-Synuclein and dopamine at the crossroads of Parkinson's disease
Lara Lourenco Venda et al.
TRENDS IN NEUROSCIENCES (2010)
Circulating interleukin-10 and interleukin-12 in Parkinson's disease
M. Rentzos et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease
David K. Stone et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
alpha-Synuclein Gene Rearrangements in Dominantly Inherited Parkinsonism Frequency, Phenotype, and Mechanisms
Pablo Ibanez et al.
ARCHIVES OF NEUROLOGY (2009)
NSAID Use and the Risk of Parkinson's Disease Systematic Review and Meta-Analysis of Observational Studies
Ali Samii et al.
DRUGS & AGING (2009)
Mitochondrial dynamics in Parkinson's disease
Victor S. Van Laar et al.
EXPERIMENTAL NEUROLOGY (2009)
Tonicity-dependent induction of Sgk1 expression has a potential role in dehydration-induced natriuresis in rodents
Songcang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2009)
Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease
Lilia Marinova-Mutafchieva et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study
Mahyar Etminan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Shaji Theodore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study
Sean S. O'Sullivan et al.
MOVEMENT DISORDERS (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
Andis Klegeris et al.
NEUROBIOLOGY OF AGING (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
Nonmotor symptoms of Parkinson's disease: Prevalence and awareness of patients and families
Sang-Myung Cheon et al.
PARKINSONISM & RELATED DISORDERS (2008)
The 6-hydroxydopamine model: News from the past
Fabio Blandini et al.
PARKINSONISM & RELATED DISORDERS (2008)
CD4+T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
David R. Beers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Angelika D. Wahner et al.
NEUROLOGY (2007)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
Uwe-Karsten Hanisch et al.
NATURE NEUROSCIENCE (2007)
Neuroinflammation in the pathophysiology of Parkinson's disease:: Evidence from animal models to human in vivo studies with [11C]-PKI1195 PET
Anna L. Bartels et al.
MOVEMENT DISORDERS (2007)
Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease
Chang-Lin Liang et al.
EXPERIMENTAL NEUROLOGY (2007)
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
Chad Laurie et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
Marjolijn Bornebroek et al.
NEUROEPIDEMIOLOGY (2007)
The role of anti-inflammatory agents in Parkinson's disease
Edith G. McGeer et al.
CNS DRUGS (2007)
Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
Marie-Therese Armentero et al.
NEUROBIOLOGY OF DISEASE (2006)
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease
Thanh G. Ton et al.
MOVEMENT DISORDERS (2006)
Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys
J Miklossy et al.
EXPERIMENTAL NEUROLOGY (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
alpha-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers
Katrin Beyer
ACTA NEUROPATHOLOGICA (2006)
Like cops on the beat: the active role of resting microglia
G Raivich
TRENDS IN NEUROSCIENCES (2005)
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
PM Carvey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Oxidative stress and inflammation in Parkinson's disease: Is there a causal link?
A Hald et al.
EXPERIMENTAL NEUROLOGY (2005)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Microglial activation and dopamine terminal loss in early Parkinson's disease
Y Ouchi et al.
ANNALS OF NEUROLOGY (2005)
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
Emilie Croisier et al.
JOURNAL OF NEUROINFLAMMATION (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Astroglial and microglial activation in the Wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine
RWP Rodrigues et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2004)
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure
C Barcia et al.
GLIA (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Minocycline enhances MPTP toxicity to dopaminergic neurons
LC Yang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
Selective microglial activation in the rat rotenone model of Parkinson's disease
TB Sherer et al.
NEUROSCIENCE LETTERS (2003)
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice
S Sugama et al.
BRAIN RESEARCH (2003)
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration
PL McGeer et al.
ANNALS OF NEUROLOGY (2003)
Mitochondrial voltage-dependent anion channel is involved in dopamine-induced apoptosis
A Premkumar et al.
JOURNAL OF NEUROCHEMISTRY (2002)
The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice -: Paraquat and α-synuclein
AB Manning-Bog et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
F Cicchetti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Pesticides directly accelerate the rate of α-synuclein fibril formation:: a possible factor in Parkinson's disease
VN Uversky et al.
FEBS LETTERS (2001)
Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine
RWP Rodrigues et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2001)
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
BI Giasson et al.
SCIENCE (2000)
Functional changes of the basal ganglia circuitry in Parkinson's disease
F Blandini et al.
PROGRESS IN NEUROBIOLOGY (2000)